13G Filing: Sabby Capital and Genetic Technologies Limited (ADR) (GENE)

Page 5 of 7 – SEC Filing

Sabby Healthcare Master Fund, Ltd.

( (i)
Sole power to vote or to direct the vote
0
,( (ii)
Shared power to vote or to direct the vote
0
,( (iii)
Sole power to dispose or to direct the disposition of
0
,( (iv)
Shared power to dispose or to direct the disposition of
0
.Sabby Management, LLC

(i)
Sole power to vote or to direct the vote
0
,( (ii)
Shared power to vote or to direct the vote
0
,( (iii)
Sole power to dispose or to direct the disposition of
0
,( (iv)
Shared power to dispose or to direct the disposition of
0
.Hal Mintz

( (i)
Sole power to vote or to direct the vote
0
,( (ii)
Shared power to vote or to direct the vote
0
,( (iii)
Sole power to dispose or to direct the disposition of
0
,( (iv)
Shared power to dispose or to direct the disposition of
0
.As calculated in accordance with Rule 13d-3 of the Securities Exchange
Act of 1934, as amended, (i) Sabby Healthcare Master Fund,
Ltd. beneficially owns 0 shares of the Issuer’s ADR
(ADR), representing approximately 0% of the ADR,
and (ii) Sabby Management, LLC and Hal Mintz each beneficially own
0 shares of the ADR, representing approximately 0% of
the ADR. Sabby Management, LLC and Hal Mintz do not directly own
any shares of ADR, but each indirectly owns 0 shares of
ADR. Sabby Management, LLC, a Delaware limited liability company,
indirectly owns 0 shares of ADR because it serves as the
investment manager of Sabby Healthcare Master Fund, Ltd. Mr.
Mintz indirectly owns 0 shares of ADR in his capacity
as manager of Sabby Management, LLC.

Item 5.
Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the
following [X].